[PDF][PDF] Formulation development evaluation and anti-inflammatory effects of etoricoxib cream
Non-Steroidal Anti-inflammatory drugs (NSAIDs) are widely employed in musculoskeletal
disease, both for their antiinflammatory as well as their analgesic properties [1]. Use of these …
disease, both for their antiinflammatory as well as their analgesic properties [1]. Use of these …
Formulation Design and In Vitro Characterization of Etoricoxib Cream for the Treatment of Rheumatoid Arthritis: Formulation Design and In-Vitro Characterization of …
Abstract Non-Steroidal Anti-inflammatory drugs (NSAIDs), including selective
cyclooxygenase (COX)-2 inhibitors, have come to play an important role in the …
cyclooxygenase (COX)-2 inhibitors, have come to play an important role in the …
Efficacy and tolerability profile of etoricoxib in patients with osteoarthritis: a randomized, double-blind, placebo and active-comparator controlled 12-week efficacy trial
AT Leung, K Malmstrom, AE Gallacher… - … medical research and …, 2002 - Taylor & Francis
Objective: To evaluate the efficacy of 12 weeks of treatment with etoricoxib, a selective COX-
2 inhibitor, in patients with osteoarthritis (OA) of the knee or hip. Methods: In the 12-week …
2 inhibitor, in patients with osteoarthritis (OA) of the knee or hip. Methods: In the 12-week …
Further assessment of the clinically effective dose range of etoricoxib: a randomized, double-blinded, placebo-controlled trial in rheumatoid arthritis
M Greenwald, PM Peloso, D Mandel… - … medical research and …, 2011 - Taylor & Francis
Objective: To further assess the clinically active dose range of etoricoxib, a COX-2 selective
inhibitor, in rheumatoid arthritis (RA). Methods: RA patients were randomized to etoricoxib …
inhibitor, in rheumatoid arthritis (RA). Methods: RA patients were randomized to etoricoxib …
Results of a randomized, dose‐ranging trial of etoricoxib in patients with osteoarthritis
K Gottesdiener, T Schnitzer, C Fisher, B Bockow… - …, 2002 - academic.oup.com
Objectives. To evaluate the clinical efficacy and tolerability of etoricoxib in the treatment of
osteoarthritis (OA) of the knee and define the clinically active dose range for further clinical …
osteoarthritis (OA) of the knee and define the clinically active dose range for further clinical …
Etoricoxib.
AK Matsumoto, PF Cavanaugh Jr - Drugs of Today (Barcelona …, 2004 - europepmc.org
Etoricoxib (Arcoxia, Merck & Co., Inc.) is a selective inhibitor of cyclooxygenase-2 (COX-2),
an enzyme involved in pain and inflammation. It is a member of the COX-2-selective (coxib) …
an enzyme involved in pain and inflammation. It is a member of the COX-2-selective (coxib) …
[HTML][HTML] Evaluation of two doses of etoricoxib, a COX-2 selective non-steroidal anti-inflammatory drug (NSAID), in the treatment of Rheumatoid Arthritis in a double …
K Bickham, AJ Kivitz, A Mehta, N Frontera… - BMC Musculoskeletal …, 2016 - Springer
Background Treatment with non-steroidal anti-inflammatory drugs (NSAID) is a common
component of treatment regimens for rheumatoid arthritis (RA). Etoricoxib is a COX-2 …
component of treatment regimens for rheumatoid arthritis (RA). Etoricoxib is a COX-2 …
Etoricoxib: a review of its use in the symptomatic treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute gouty arthritis
KF Croom, MAA Siddiqui - Drugs, 2009 - Springer
Etoricoxib is a selective cyclo-oxygenase (COX)-2 inhibitor, approved in Europe for the
symptomatic treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and …
symptomatic treatment of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and …
[PDF][PDF] A comparative study to assess the safety and efficacy of etoricoxib versus aceclofenac in osteoarthritis
Background: Osteoarthritis (OA) is most common form of arthritis; also referred as
degenerative joint disease or “wear and tear” arthritis. Cyclooxygenase-2 (COX-2) inhibitors …
degenerative joint disease or “wear and tear” arthritis. Cyclooxygenase-2 (COX-2) inhibitors …
[HTML][HTML] A multinational randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis [ISRCTN25142273]
E Collantes, SP Curtis, KW Lee, N Casas… - BMC Family …, 2002 - Springer
Background Etoricoxib is a highly selective COX-2 inhibitor which was evaluated for the
treatment of rheumatoid arthritis (RA). Methods Double-blind, randomized, placebo and …
treatment of rheumatoid arthritis (RA). Methods Double-blind, randomized, placebo and …